Le Lézard
Classified in: Health, Business
Subject: BOARD OF DIRECTORS

KFSH&RC Welcomes Dr. Björn Zoéga as New Deputy CEO



RIYADH, Saudi Arabia, April 02, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH&RC) is proud to announce the appointment of Dr. Björn Zoéga as Deputy Chief Executive Officer (CEO), effective 01 April 2024. This strategic move is set to accelerate KFSH&RC's aspiration of becoming a leading healthcare institution on the global stage, leveraging Dr. Zoéga's notable career and proven track record of leadership in top-tier medical institutions.

As the former CEO of the internationally renowned Karolinska University Hospital in Sweden, Dr. Zoéga played a pivotal role in upholding the institution's high standards and global recognition as the second highest rated among European hospitals and seventh best worldwide according to Newsweek's ranking of the World's Best Hospitals 2024. His administration at Karolinska was marked by innovative strategies and excellence in healthcare delivery?all which he is posed to enrich within KFSH&RC.

Dr. Zoégabrings decades of healthcare management and clinical expertise to KFSH&RC, having spearheaded operations as CEO of the National University Hospital of Iceland and the Stockholm Spine Center. His experience and faculties in research and education are also invaluable, given his former roles as President and Board Chairman of the EU-Cervical Spine Research Society and Chairman of the Scientific Advisory Board of Alvotech.

As Deputy CEO, Dr. Zoéga will serve as chief lead of KFSH&RC's healthcare delivery and research and innovation groups, following on the hospital's commitment to integrating global best practices in healthcare and pursuing cutting-edge medical research and technology.

KFSH&RC extends its invitation to the community, partners, and stakeholders to welcome Dr. Björn Zoéga, as the institution embarks on a promising new chapter in healthcare, committed to fostering a brighter and healthier future for all.

For more information, please contact:

Mr. Essam Al-Zahrani, Media Affairs Acting Head, 0555254429

Mr. Abdullah Al-Awn, Senior Media Editor, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5-9219-4e72-82fd-8f093f22996e 



These press releases may also interest you

7 mai 2024
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...

7 mai 2024
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...

7 mai 2024
Today, The Kids Mental Health Foundation (KMHF) hosted a panel alongside the Mental Health Storytelling, which is housed at the USC Annenberg Inclusion Initiative, in New York City. The...

7 mai 2024
The Board of Juno Pharmaceuticals Corporation is excited to announce the appointment of Jean-Guy Goulet as Chief Executive Officer (CEO). An executive with over 35 years of experience in the pharmaceutical industry, overseeing activities in Canada...

7 mai 2024
Mexico's pharmaceutical and personal care industry is undergoing significant changes with the strategic moves announced by Genomma Lab International, S.A.B. de C.V. (B.M.V.: LABB) regarding its agreement to redeem capital in Marzam. The...

7 mai 2024
Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES The updated release reads: ZYUS LIFE SCIENCES CORPORATION TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE MAY 8-9 NOT FOR...



News published on and distributed by: